ERBB2 and breast carcinoma: Breast cancer is a heterogeneous disease for which a molecular classification has been compiled based on the expression of biomarkers, including estrogen/progesterone receptors (ERα/PR) and human epidermal growth factor receptor-2 (HER2) [2,3].